Compare with Merck KGaA


Market capitalization
‪61.69 B‬ EURLarge cap
5.45 EUR
‪2.61 B‬ EUR
‪21.10 B‬ EUR
‪125.42 M‬
Beta (1Y)
1.24
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Employees (FY)
‪62.46 K‬
Change (1Y)
−96−0.15%
Revenue / Employee (1Y)
‪337.84 K‬ EUR
Net income / Employee (1Y)
‪41.75 K‬ EUR

Company info


CEO
Kai Beckmann
Headquarters
Darmstadt
IPO date
Oct 20, 1995
ISIN
DE0006599905
CFI code
ESVUFB
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateJul 5, 2031
Coupon0.88% (Fixed)
Maturity dateJun 15, 2030
Coupon2.38% (Fixed)
Maturity dateJul 16, 2028
Coupon0.50% (Fixed)
Maturity dateJul 5, 2027
Coupon0.38% (Fixed)
Maturity dateJun 25, 2079
Coupon2.88% (Variable)
Maturity dateNov 24, 2055
Coupon3.75% (Variable)
Maturity dateAug 27, 2054
Coupon3.88% (Variable)

See all MRK bonds 

Weight0.05%
Market value‪307.82 M‬
Weight0.06%
Market value‪204.19 M‬
Weight0.08%
Market value‪155.81 M‬
Weight1.06%
Market value‪102.60 M‬
Weight1.06%
Market value‪102.60 M‬
Weight1.06%
Market value‪83.30 M‬
Weight1.06%
Market value‪83.30 M‬
Weight5.09%
Market value‪77.53 M‬
Weight5.09%
Market value‪77.53 M‬
Weight0.10%
Market value‪73.50 M‬

Explore more ETFs 

Frequently asked questions


The current price of MRK is 143.00 EUR — it has increased by 1.36% in the past 24 hours. Watch Merck KGaA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSESOF exchange Merck KGaA stocks are traded under the ticker MRK.
MRK stock has risen by 1.55% compared to the previous week, the month change is a 6.44% rise, over the last year Merck KGaA has showed a 21.96% increase.
We've gathered analysts' opinions on Merck KGaA future price: according to them, MRK price has a max estimate of 179.00 EUR and a min estimate of 135.00 EUR. Watch MRK chart and read a more detailed Merck KGaA stock forecast: see what analysts think of Merck KGaA and suggest that you do with its stocks.
MRK reached its all-time high on Nov 19, 2021 with the price of 223.10 EUR, and its all-time low was 105.25 EUR and was reached on Aug 7, 2025. View more price dynamics on MRK chart.
See other stocks reaching their highest and lowest prices.
MRK stock is 1.19% volatile and has beta coefficient of 1.24. Track Merck KGaA stock price on the chart and check out the list of the most volatile stocks — is Merck KGaA there?
Today Merck KGaA has the market capitalization of ‪61.69 B‬, it has increased by 0.65% over the last week.
Yes, you can track Merck KGaA financials in yearly and quarterly reports right on TradingView.
Merck KGaA is going to release the next earnings report on Nov 12, 2026. Keep track of upcoming events with our Earnings Calendar.
MRK earnings for the last quarter are 2.16 EUR per share, whereas the estimation was 2.03 EUR resulting in a 6.61% surprise. The estimated earnings for the next quarter are 2.09 EUR per share. See more details about Merck KGaA earnings.
Merck KGaA revenue for the last quarter amounts to ‪5.43 B‬ EUR, despite the estimated figure of ‪5.29 B‬ EUR. In the next quarter, revenue is expected to reach ‪5.41 B‬ EUR.
MRK net income for the last quarter is ‪490.00 M‬ EUR, while the quarter before that showed ‪660.00 M‬ EUR of net income which accounts for 0.00% change. Track more Merck KGaA financial stats to get the full picture.
Yes, MRK dividends are paid annually. The last dividend per share was 2.20 EUR. As of today, Dividend Yield (TTM)% is 1.55%. Tracking Merck KGaA dividends might help you take more informed decisions.
Merck KGaA dividend yield was 1.79% in 2025, and payout ratio reached 36.68%. The year before the numbers were 1.57% and 34.44% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 16, 2026, the company has ‪62.46 K‬ employees. See our rating of the largest employees — is Merck KGaA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck KGaA EBITDA is ‪6.59 B‬ EUR, and current EBITDA margin is 28.17%. See more stats in Merck KGaA financial statements.
Like other stocks, MRK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck KGaA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck KGaA technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck KGaA stock shows the buy signal. See more of Merck KGaA technicals for a more comprehensive analysis.